Showing results (991-1000 of 1,341) with videos related to

Sort By:
Pageof 135
Neuro-Oncology Advances|August 23, 2026
Outcomes of target therapies for pediatric BRAF V600-mutant low-grade gliomas: A systematic review and meta-analysisKatherine Figueira, Laura Elin Pigott
Neuro-Oncology Advances|August 8, 2026
A fluorescein-conjugated somatostatin receptor antagonist adapter for chimeric antigen receptor T cell therapy of meningiomaJiawei Chen, Christian Pellegrino, Maximilian Mastall, et al.
Neuro-Oncology Advances|August 9, 2026
A clinical decision-support framework to differentiate radiation necrosis from tumor progression in brain metastasesBeatriz Ocaña-Tienda, Zhao Hui Chen Zhou, Ana Ramos, et al.
Neuro-Oncology Advances|August 13, 2026
Immunogenomic profiling reveals targets for gene therapy in pediatric brain tumorsGiulia Rovesti, Alejandro Fernandez Woodbridge, Haidong Yao, et al.
Neuro-Oncology Advances|August 21, 2026
Hypothalamic obesity following craniopharyngioma surgery: What is the role of hypothalamic T2 signal changes in brain MRI?Doga Yurddas, Rutger A J Nievelstein, Brigitte Bison, et al.
Neuro-Oncology Advances|August 20, 2026
Beyond the typical immune effector cell-associated neurotoxicity syndrome: Characterizing non-immune effector cell-associated neurotoxicity syndrome neurological complications in chimeric antigen receptor T-cell therapy-A retrospective analysisMelissa A Nicholas, Abdulaziz Abu-Haimed, Faisal Abushullaih, et al.
Neuro-Oncology Advances|September 8, 2026
Metabolomic and lipidomic profiling reveals distinct subtypes of glioblastoma IDH-wildtype and shared metabolic features with astrocytoma IDH-mutant grade 4John Paul Aboubechara, Yin Liu, Oliver Fiehn, et al.
Neuro-Oncology Advances|September 9, 2026
Perineuronal net degradation in aggressive glioblastomas with KANK1::NTRK2 fusionsMadhumala K Sadanandappa, Nishika Karbhari, Brizha Knowles, et al.
Neuro-Oncology Advances|September 9, 2026
Correction to: Exploring relationships between abnormal within-network functional connectivity, preoperative brain tumor variables, and neuropsychological test scores
Neuro-Oncology Advances|September 10, 2026
[18F]FET PET imaging for early response assessment of bevacizumab in recurrent glioblastomaShivani Chiranth, Otto Mølby Henriksen, Benedikte Hasselbalch, et al.
Pageof 135